Dr. Daniel Von Hoff - Kinex Pharmaceuticals
Dr. Daniel Von Hoff has joined Kinex Pharmaceuticals as Chair of its Clinical Advisory Committee.
Von Hoff is the current Physician-in-Chief at the Translational Genomics Research Institute (TGen), and Professor of Medicine at the Mayo Clinic and his “remarkable breadth of experience will be a great resource for Kinex,” according to Dr. Rudolf Kwan, Chief Medical Officer of Kinex.
“His contributions to the clinical investigation successes of paclitaxel, docetaxel, irinotecan, and nab-paclitaxel will prove invaluable to a number of our existing and planned clinical efforts, including Oraxol and Oratecan. Further, his current work with new anticancer agents will help Kinex explore additional potential opportunities for KX01 and to further optimize our KX02 program.”
